208 related articles for article (PubMed ID: 19147767)
21. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
Ravichandran K; Velmurugan B; Gu M; Singh RP; Agarwal R
Clin Cancer Res; 2010 Sep; 16(18):4595-606. PubMed ID: 20823143
[TBL] [Abstract][Full Text] [Related]
22. Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels.
Singh RP; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Cancer Res; 2002 Jun; 62(11):3063-9. PubMed ID: 12036915
[TBL] [Abstract][Full Text] [Related]
23. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
24. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
Tyagi A; Sharma Y; Agarwal C; Agarwal R
Pharm Res; 2008 Sep; 25(9):2143-50. PubMed ID: 18253818
[TBL] [Abstract][Full Text] [Related]
25. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
Cui W; Gu F; Hu KQ
World J Gastroenterol; 2009 Apr; 15(16):1943-50. PubMed ID: 19399925
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
Tyagi A; Agarwal C; Agarwal R
Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
[TBL] [Abstract][Full Text] [Related]
27. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.
Zi X; Agarwal R
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7490-5. PubMed ID: 10377442
[TBL] [Abstract][Full Text] [Related]
28. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.
Singh RP; Dhanalakshmi S; Mohan S; Agarwal C; Agarwal R
Mol Cancer Ther; 2006 May; 5(5):1145-53. PubMed ID: 16731746
[TBL] [Abstract][Full Text] [Related]
29. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo.
Kim KW; Choi CH; Kim TH; Kwon CH; Woo JS; Kim YK
Neurochem Res; 2009 Aug; 34(8):1479-90. PubMed ID: 19263218
[TBL] [Abstract][Full Text] [Related]
30. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
[TBL] [Abstract][Full Text] [Related]
31. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways.
Duan WJ; Li QS; Xia MY; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2011; 34(1):47-53. PubMed ID: 21212516
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
33. A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.
Anestopoulos I; Sfakianos AP; Franco R; Chlichlia K; Panayiotidis MI; Kroll DJ; Pappa A
Molecules; 2016 Dec; 22(1):. PubMed ID: 28042859
[TBL] [Abstract][Full Text] [Related]
34. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.
Deep G; Gangar SC; Agarwal C; Agarwal R
Cancer Prev Res (Phila); 2011 Aug; 4(8):1222-32. PubMed ID: 21546539
[TBL] [Abstract][Full Text] [Related]
35. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Int J Cancer; 2008 Jul; 123(1):41-50. PubMed ID: 18435416
[TBL] [Abstract][Full Text] [Related]
36. Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.
Nambiar DK; Rajamani P; Deep G; Jain AK; Agarwal R; Singh RP
Mol Cancer Ther; 2015 Dec; 14(12):2722-34. PubMed ID: 26516160
[TBL] [Abstract][Full Text] [Related]
37. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
[TBL] [Abstract][Full Text] [Related]
38. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling.
Raina K; Agarwal C; Agarwal R
Mol Carcinog; 2013 Mar; 52(3):195-206. PubMed ID: 22086675
[TBL] [Abstract][Full Text] [Related]
39. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
Wang YX; Cai H; Jiang G; Zhou TB; Wu H
Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
[TBL] [Abstract][Full Text] [Related]
40. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules.
Velmurugan B; Gangar SC; Kaur M; Tyagi A; Deep G; Agarwal R
Pharm Res; 2010 Oct; 27(10):2085-97. PubMed ID: 20628792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]